Deep Dive: A Capital Planning Executive’s Perspective on Trends In the BioPharma Industry

Deep Dive: A Capital Planning Executive’s Perspective on Trends In the BioPharma Industry The biotech and pharmaceutical sectors flourished in 2021 due to a low-interest rate environment and strong pandemic-driven demand, achieving top-line growth of over 30%. However, 2022 proved to be quieter as financing waned and large companies shifted their focus to divesting non-core […]

Zero-based budgeting for Capex: the post-pandemic view

Zero-based budgeting for Capex: the post-pandemic view Coming out of the worst of COVID, we’re all ready to wipe the slate clean and start fresh. Why not do the same with your budgeting process? Zero-based budgeting (ZBB) has gained renewed interest post-pandemic as a way to ensure that expenses are aligned with organizational objectives. So, […]